BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32719250)

  • 1. Biochemical analysis of cytokeratin fragment 21-1 concentration and expression of cytokeratin 19 in oral potentially malignant disorders.
    Rathore AS; Katyal S; Jain A; Shetty DC
    J Cancer Res Ther; 2020; 16(3):452-457. PubMed ID: 32719250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Cyfra 21-1 concentration in saliva from primary oral squamous cell carcinoma patients.
    Zhong LP; Zhang CP; Zheng JW; Li J; Chen WT; Zhang ZY
    Arch Oral Biol; 2007 Nov; 52(11):1079-87. PubMed ID: 17612501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of Cyfra 21-1 levels in saliva and serum with CK19 mRNA expression in oral squamous cell carcinoma.
    Malhotra R; Urs AB; Chakravarti A; Kumar S; Gupta VK; Mahajan B
    Tumour Biol; 2016 Jul; 37(7):9263-71. PubMed ID: 26779624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary and serum level of CYFRA 21-1 in oral precancer and oral squamous cell carcinoma.
    Rajkumar K; Ramya R; Nandhini G; Rajashree P; Ramesh Kumar A; Nirmala Anandan S
    Oral Dis; 2015 Jan; 21(1):90-6. PubMed ID: 24304502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of cytokeratin 19 in the development and progression of oral squamous cell carcinoma].
    Tan D; Li CH; Nie MH
    Shanghai Kou Qiang Yi Xue; 2016 Oct; 25(5):600-603. PubMed ID: 28116435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive bioassay of Cytokeratin Fragment 21.1 (Cyfra 21.1) protein in human saliva samples using immunoreaction method: An efficient platform for early-stage diagnosis of oral cancer based on biomedicine.
    Jafari M; Hasanzadeh M
    Biomed Pharmacother; 2020 Nov; 131():110671. PubMed ID: 32853907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of protein-based salivary markers in the diagnosis of oral potentially malignant disorders: A systematic review and meta-analysis.
    Arroyo E; Donís SP; Petronacci CMC; Alves MGO; Mendía XM; Fernandes D; Pouso AIL; Bufalino A; Bravo López S; Sayáns MP
    Cancer Biomark; 2021; 32(4):411-424. PubMed ID: 34334380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokeratin 19 expression in early oral squamous cell carcinoma and their metastasis: Inadequate biomarker for one-step nucleic acid amplification implementation in sentinel lymph node biopsy procedure.
    Noorlag R; van Es RJJ; de Bree R; Willems SM
    Head Neck; 2017 Sep; 39(9):1864-1868. PubMed ID: 28644540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Salivary Biomarkers for Oral Cancer Detection with Untargeted and Targeted Quantitative Proteomics Approaches.
    Chu HW; Chang KP; Hsu CW; Chang IY; Liu HP; Chen YT; Wu CC
    Mol Cell Proteomics; 2019 Sep; 18(9):1796-1806. PubMed ID: 31253657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Diagnostic Significance of Salivary miRNA-184 and miRNA-21 in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.
    Garg A; Urs AB; Koner BC; Augustine J; Guru SA
    Head Neck Pathol; 2023 Dec; 17(4):961-968. PubMed ID: 38015343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary MMP-9 as a Biomarker for the Diagnosis of Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma.
    Smriti K; Ray M; Chatterjee T; Shenoy RP; Gadicherla S; Pentapati KC; Rustaqi N
    Asian Pac J Cancer Prev; 2020 Jan; 21(1):233-238. PubMed ID: 31983189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saliva protein biomarkers to detect oral squamous cell carcinoma in a high-risk population in Taiwan.
    Yu JS; Chen YT; Chiang WF; Hsiao YC; Chu LJ; See LC; Wu CS; Tu HT; Chen HW; Chen CC; Liao WC; Chang YT; Wu CC; Lin CY; Liu SY; Chiou ST; Chia SL; Chang KP; Chien CY; Chang SW; Chang CJ; Young JD; Pao CC; Chang YS; Hartwell LH
    Proc Natl Acad Sci U S A; 2016 Oct; 113(41):11549-11554. PubMed ID: 27663741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue.
    Coltrera MD; Zarbo RJ; Sakr WA; Gown AM
    Am J Pathol; 1992 Oct; 141(4):817-25. PubMed ID: 1384338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological significance of combined analysis of cytokeratin19 expression and preoperative serum CYFRA21-1 levels in human lung squamous cell carcinoma.
    Hanada S; Nishiyama N; Mizuguchi S; Yamano S; Kakehashi A; Wei M; Inoue H; Komatsu H; Chung K; Suehiro S; Wanibuchi H
    Osaka City Med J; 2013 Jun; 59(1):35-44. PubMed ID: 23909079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salivary Her2/neu Levels in Differentiation of Oral Premalignant Disorders and Oral Squamous Cell Carcinomas.
    Varun C; Dineshkumar T; Jayant VS; Rameshkumar A; Rajkumar K; Rajashree P; Mathew J; Arunvignesh RK
    Asian Pac J Cancer Prev; 2015; 16(14):5773-7. PubMed ID: 26320450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of serum CK19-2G2 and Cyfra21-1 protein and comparison of their diagnostic value for lung cancer].
    Gao J; Wang H; Qi J
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):930-2. PubMed ID: 19173996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic value of cytokeratin 19 fragment in nasopharyngeal carcinoma].
    Lei DS; Yu J; Tong XL; Wang MW; Wang K; Chen H
    Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):461-5. PubMed ID: 22932457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence-based immunosensor using three-dimensional CNT network structure for sensitive and reproducible detection of oral squamous cell carcinoma biomarker.
    Song CK; Oh E; Kang MS; Shin BS; Han SY; Jung M; Lee ES; Yoon SY; Sung MM; Ng WB; Cho NJ; Lee H
    Anal Chim Acta; 2018 Oct; 1027():101-108. PubMed ID: 29866259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of serum and salivary tumor necrosis factor-α with histological grading in oral cancer and its role in differentiating premalignant and malignant oral disease.
    Krishnan R; Thayalan DK; Padmanaban R; Ramadas R; Annasamy RK; Anandan N
    Asian Pac J Cancer Prev; 2014; 15(17):7141-8. PubMed ID: 25227804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of serum and salivary sialic acid in oral cancer diagnostics.
    Guruaribam VD; Sarumathi T
    J Cancer Res Ther; 2020; 16(3):401-404. PubMed ID: 32719243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.